Total Payments
$15,836
2024 Payments
$32.90
Companies
61
Transactions
987
Medicare Patients
1,435
Medicare Billing
$135,873
Payment Breakdown by Category
Food & Beverage$15,407 (97.3%)
Other$428.28 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,407 | 963 | 97.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $428.28 | 24 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $1,338 | 73 | $0 (2022) |
| Biogen, Inc. | $1,141 | 80 | $0 (2023) |
| ABBVIE INC. | $1,078 | 90 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $959.42 | 54 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $828.49 | 68 | $0 (2024) |
| EMD Serono, Inc. | $747.62 | 51 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $642.89 | 32 | $0 (2023) |
| Amgen Inc. | $610.85 | 33 | $0 (2022) |
| Neurelis, Inc. | $592.43 | 24 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $486.11 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.90 | 1 | Novartis Pharmaceuticals Corporation ($32.90) |
| 2023 | $2,105 | 125 | ABBVIE INC. ($543.97) |
| 2022 | $2,723 | 178 | Avanir Pharmaceuticals, Inc. ($267.73) |
| 2021 | $2,539 | 154 | Neurelis, Inc. ($349.32) |
| 2020 | $1,971 | 123 | Supernus Pharmaceuticals, Inc. ($252.11) |
| 2019 | $2,238 | 137 | Supernus Pharmaceuticals, Inc. ($288.65) |
| 2018 | $2,047 | 118 | Biogen, Inc. ($341.70) |
| 2017 | $2,180 | 151 | Biogen, Inc. ($363.61) |
All Payment Transactions
987 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: Neurology | ||||||
| 11/29/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Neurology | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Neurology | ||||||
| 10/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Neurology | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Neurology | ||||||
| 08/15/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Central Nervous System | ||||||
| 08/12/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Central Nervous System | ||||||
| 08/11/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Neurology | ||||||
| 08/11/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: Neurology | ||||||
| 08/10/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | Jazz Pharmaceuticals Inc. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: NEUROLOGY | ||||||
| 08/07/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Immunology | ||||||
| 08/01/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.08 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $18.20 | General |
| Category: Neurology | ||||||
| 07/27/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: EPILEPSY | ||||||
| 07/25/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Rare Disease | ||||||
| 07/19/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 07/19/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.68 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 149 | 190 | $42,293 | $14,196 |
| 2022 | 10 | 380 | 453 | $100,680 | $37,143 |
| 2021 | 11 | 443 | 492 | $114,992 | $45,055 |
| 2020 | 10 | 463 | 542 | $110,979 | $39,479 |
Total Patients
1,435
Total Services
1,677
Medicare Billing
$135,873
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 80 | $19,440 | $6,456 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 87 | $14,964 | $4,792 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 23 | $7,889 | $2,948 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 139 | $29,595 | $11,451 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 57 | $16,611 | $6,691 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 76 | $11,497 | $4,641 | 40.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 42 | 44 | $12,108 | $4,111 | 33.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 42 | 43 | $10,988 | $3,825 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $9,046 | $3,097 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $4,958 | $1,889 | 38.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 19 | 19 | $3,268 | $791.82 | 24.2% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 11 | 11 | $1,048 | $334.04 | 31.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 11 | 11 | $1,561 | $313.37 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 103 | 131 | $26,462 | $11,753 | 44.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 66 | 78 | $21,294 | $9,786 | 46.0% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 54 | 54 | $13,716 | $4,629 | 33.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $10,557 | $4,456 | 42.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $11,780 | $4,251 | 36.1% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 41 | 43 | $11,825 | $4,238 | 35.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 61 | $8,357 | $3,015 | 36.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 22 | 22 | $3,784 | $937.39 | 24.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,222 | $933.29 | 42.0% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 15 | 15 | $3,315 | $631.68 | 19.1% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2021 | 12 | 12 | $1,680 | $425.52 | 25.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 86 | 112 | $30,576 | $11,711 | 38.3% |
About Dr. John Grubbs, MD
Dr. John Grubbs, MD is a Neurology healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710077110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Grubbs, MD has received a total of $15,836 in payments from pharmaceutical and medical device companies, with $32.90 received in 2024. These payments were reported across 987 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($15,407).
As a Medicare-enrolled provider, Grubbs has provided services to 1,435 Medicare beneficiaries, totaling 1,677 services with total Medicare billing of $135,873. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Paducah, KY
- Active Since 10/14/2006
- Last Updated 12/03/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1710077110
Products in Payments
- NUEDEXTA (Drug) $1,044
- TECFIDERA (Drug) $768.94
- OXTELLAR XR (Drug) $758.79
- NUPLAZID (Drug) $642.89
- VALTOCO (Drug) $592.43
- Aimovig (Biological) $580.22
- KESIMPTA (Drug) $525.74
- UBRELVY (Drug) $512.55
- NURTEC ODT (Drug) $511.77
- EMGALITY (Drug) $417.06
- Hizentra (Biological) $389.75
- APTIOM (Drug) $383.38
- VNS Therapy (Device) $378.24
- ACTHAR (Biological) $347.03
- Nuedexta (Drug) $311.25
- INBRIJA (Drug) $281.33
- INGREZZA (Drug) $280.53
- OCREVUS (Biological) $268.95
- ZEPOSIA (Drug) $254.55
- BOTOX (Biological) $250.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.